Mruthyunjaya Prithvi, Jumper J Michael, McCallum Rex, Patel Divya J, Cox Terry A, Jaffe Glenn J
Department of Ophthalmology, Duke University Eye Center, Durham, North Carolina 27710, USA.
Ophthalmology. 2002 Jun;109(6):1123-9. doi: 10.1016/s0161-6420(02)01033-3.
To determine the yield of diagnostic pars plana vitrectomy in eyes with suspected posterior segment inflammation or malignancy when clinical examination and systemic laboratory testing did not yield a specific diagnosis.
Non-comparative interventional case series
Eighty-seven consecutive patients (90 eyes) who underwent diagnostic pars plana vitrectomy from 1989 through 1999.
Vitreous samples were analyzed in a directed manner based on the preoperative clinical examination and systemic laboratory testing.
Diagnosis from each test performed on the vitreous samples.
Diagnostic vitrectomy was performed alone in 6 eyes (7%) and as part of a therapeutic procedure in the remaining 84 eyes. The diagnostic tests performed most frequently included cytopathology (83%), microbiologic culture and sensitivity (43%), polymerase chain reaction (PCR) (36%), and intraocular antibody levels for T. canis (14%). Of these, intraocular antibody testing and PCR had the highest positive yield, 46% and 39%, respectively. Overall, directed vitreous analysis identified a specific cause in 35 eyes (39%). Of the 65 cases in which an underlying infection was suspected preoperatively, the procedure yielded a specific diagnosis in 27 (42%). When intraocular malignancy was considered preoperatively (71 eyes), a diagnosis of intraocular lymphoma was obtained in seven (10%). This difference between these diagnostic yields was significant (P = 0.02, Fisher's exact test).
Diagnostic vitrectomy with directed vitreous fluid analysis yields a specific cause and guides subsequent therapy in a high percentage of cases. This procedure is a valuable adjunct in cases that cannot be diagnosed by less invasive methods.
当临床检查和全身实验室检测未能得出明确诊断时,确定诊断性玻璃体切割术对疑似眼后段炎症或恶性肿瘤患者的诊断率。
非对照性干预病例系列
1989年至1999年连续接受诊断性玻璃体切割术的87例患者(90只眼)。
根据术前临床检查和全身实验室检测结果,有针对性地分析玻璃体样本。
对玻璃体样本进行的各项检测得出的诊断结果。
仅6只眼(7%)单独进行了诊断性玻璃体切割术,其余84只眼作为治疗程序的一部分进行。最常进行的诊断性检测包括细胞病理学(83%)、微生物培养及药敏试验(43%)、聚合酶链反应(PCR)(36%)和犬弓首线虫眼内抗体水平检测(14%)。其中,眼内抗体检测和PCR的阳性率最高,分别为46%和39%。总体而言,有针对性的玻璃体分析在35只眼(39%)中确定了具体病因。在术前怀疑存在潜在感染的65例病例中,该手术在27例(42%)中得出了具体诊断。术前考虑眼内恶性肿瘤的71只眼中,有7只(10%)诊断为眼内淋巴瘤。这些诊断率之间的差异具有统计学意义(P = 0.02,Fisher精确检验)。
通过有针对性的玻璃体液分析进行诊断性玻璃体切割术,在很大比例的病例中可确定具体病因并指导后续治疗。该手术对于无法通过侵入性较小的方法进行诊断的病例是一种有价值的辅助手段。